Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: J Mol Cell Cardiol. 2010 Jan 4;48(6):1169–1179. doi: 10.1016/j.yjmcc.2009.12.019

Figure 7. KChIP2 inhibits MAPkinases activity.

Figure 7

The effect of KChIP2 on ERK (A) and JNK (B) activities was evaluated in neonatal myocytes infected with Ad.β-gal or Ad.KChIP2 in the presence (+) or absence (−) of AngII (1 µM for 30 min). Immunoblots were probed with phospho-specific antibodies against ERK and JNK and then re-probed for the corresponding total protein that confirmed equivalent protein loadings. Shown are representative blots from 4 determinations. * P< 0.01 Ad.KChIP2 vs. Ad.β-gal.